Background: The number of all notified TB cases decreased in the year 2002. 1200 (11.8/100,000) cases of new TB diseases and relapses were reported in the year 2002. 972(9.6/100,000) were pulmonary TB and from them 658 (6.4/100,000) were confirmed pulmonary cases.
Methods And Results: The decreasing trend in TB incidence, reported since 1999, has continued. The treatment of confirmed pulmonary cases notified in 2001 and evaluated in 2002 was effective. Treatment success was in 71% of cases, but failures and interrupted were only 3.3%. Results of treatment were affected by many patients who died for other reason then TB, because they were from the oldest group of population. We have no influence on these deaths. The resistance for AT drugs was less then 7% and MDR cases were less the 2%.
Conclusion: The low level of resistance and the effectiveness of treatment allow presuming a further decrease of TB cases. Next target of TB control should be active case finding in high-risk groups and monitoring latent infection.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Paying for home care out-of-pocket is common and costly across the income spectrum among older adults.
Health Aff Sch
January 2025
Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Many older adults with personal care needs rely on paid caregivers to remain in the community ("home care"). Those without Medicaid or private long-term-care insurance must pay out-of-pocket for care. We used the Health and Retirement Study to identify the prevalence and financial burden of paying for home care out-of-pocket in 2002-2018, by income and dementia status.
View Article and Find Full Text PDFPost-transplant TKIs for Ph+ ALL: practices to date and clinical significance.
Int J Hematol
January 2025
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Post-transplant tyrosine kinase inhibitors (TKIs) show promise in preventing relapse after allogeneic hematopoietic cell transplantation (allo-HCT) for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). However, their real-world use and efficacy remain unclear. A comprehensive study across seven centers included Ph+ALL patients who underwent allo-HCT between 2002 and 2022.
View Article and Find Full Text PDFA prospective study of the association between lifestyle and the risk of depressive symptoms.
J Affect Disord
January 2025
Department of Epidemiology, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima 960-1295, Japan; Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima 960-1295, Japan. Electronic address:
Background: Few studies have prospectively, comprehensively, and by sex, examined the relationship between lifestyle and depressive symptoms. This study aimed to longitudinally examine which lifestyle factors are associated with depressive symptoms in a large cohort of Japanese participants stratified by sex.
Methods: Among 9087 office and community-based residents who attended a health measurement course at the Osaka Medical Center for Health Science and Promotion between 2001 and 2002, 6629 individuals (3962 men and 2667 women) without prior depressive symptoms were followed until the end of March 2012 to observe the associations between lifestyle factors and the development of new depressive symptoms.
Cancer statistics, 2025.
CA Cancer J Clin
January 2025
Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2021) and mortality data collected by the National Center for Health Statistics (through 2022). In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2022, averting nearly 4.
View Article and Find Full Text PDFMortality in patients with Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors.
J Rheumatol
January 2025
J. L. Andréu Sánchez, PhD, Rheumatology department, Puerta de Hierro Majadahonda University Hospital, Autonoma University, Madrid, Spain.
Objective: To quantify the mortality risk in a large, well-characterized cohort of Sjögren's disease (SjD) patients and to identify independent predictors of mortality in this population.
Methods: We included 314 patients diagnosed with SjD according to the 2002 American-European Consensus Group criteria from a prospective, multicenter SjögrenSER-PROS cohort. Detailed data on systemic manifestations, serological markers, disease activity, and mortality was collected after 9 years of follow up.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!